Scotland · NHS Scotland MSAN
Minims® Oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit dose
MSAN(2023)18 · Level 3 · issued 29 Aug 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Proxymetacaine 0.5% eye drops 0.5ml unit dose are in limited supply until early October 2023. | Limited supply | early October 2023 |
| 3. Minims® Tetracaine Hydrochloride 0.5% w/v and 1% w/v eye drop solution remain available but | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.